Baidu
map

重磅:新冠病毒疫苗接种技术指南(第一版)公布!既往新冠感染者可在半年后接种1剂疫苗

2021-03-29 国家卫健委 国家卫健委

第一版新冠疫苗接种技术指南来了!

3月29日,国家卫健委发布《新冠疫苗接种技术指南》,指出:①60岁以上人群,建议接种;②既往新冠感染者可在半年后接种1剂疫苗;③暂不推荐18岁以下人群接种新冠疫苗;④其他疫苗与新冠疫苗接种间隔应大于14天;⑤女性不必仅因接种疫苗而延迟怀孕计划;⑥哺乳期女性接种后建议继续母乳喂养。

指南具体内容如下:

目前,我国已有5个生产企业的新冠病毒疫苗批准附条件上市或紧急使用。附条件批准上市的3个灭活疫苗和腺病毒载体疫苗Ⅲ期临床试验期中分析结果显示,疫苗保护效力均达到国家药品监督管理局《新型冠状病毒预防用疫苗临床评价指导原则(试行)》的要求,也符合世界卫生组织《新冠病毒疫苗目标产品特性》推荐的指标要求。临床试验和紧急使用阶段及前期重点人群较大规模接种后疑似预防接种异常反应监测数据表明,新冠病毒疫苗安全性良好。获批紧急使用的重组新冠病毒疫苗(CHO细胞)Ⅱ期临床试验结果显示具有良好的免疫原性和安全性

基于我国获批疫苗的临床试验研究数据和新冠肺炎的流行病学特征,中国疾病预防控制中心新冠病毒疫苗工作组起草了本指南,并经国家免疫规划专家咨询委员会审议通过。

本指南供各级卫生健康部门、疾控机构指导预防接种单位开展新冠病毒疫苗预防接种使用。

一、疫苗种类

(一)灭活疫苗。

附条件批准上市的3个新冠病毒灭活疫苗产品分别由国药集团中国生物北京生物制品研究所有限责任公司(北京所)、武汉生物制品研究所有限责任公司(武汉所)和北京科兴中维生物技术有限公司(科兴中维)生产。其原理是使用非洲绿猴肾(Vero)细胞进行病毒培养扩增,经β丙内酯灭活病毒,保留抗原成分以诱导机体产生免疫应答,并加用氢氧化铝佐剂以提高免疫原性。

(二)腺病毒载体疫苗。

附条件批准上市的腺病毒载体疫苗为康希诺生物股份公司(康希诺)生产的重组新冠病毒疫苗(5型腺病毒载体)。其原理是将新冠病毒的刺突糖蛋白(S蛋白)基因重组到复制缺陷型的人5型腺病毒基因内,基因重组腺病毒在体内表达新冠病毒S蛋白抗原,诱导机体产生免疫应答。

(三)重组亚单位疫苗。

获批紧急使用的重组亚单位疫苗为安徽智飞龙科马生物制药有限公司(智飞龙科马)生产的重组新冠病毒疫苗(CHO细胞)。其原理是将新冠病毒S蛋白受体结合区(RBD)基因重组到中国仓鼠卵巢(CHO)细胞基因内,在体外表达形成RBD二聚体,并加用氢氧化铝佐剂以提高免疫原性。

二、推荐免疫程序

(一)适用对象。

18周岁及以上人群。

(二)接种剂次和间隔。

1.新冠病毒灭活疫苗(Vero细胞)

接种2剂;2剂之间的接种间隔建议≥3周,第2剂在8周内尽早完成。

2.重组新冠病毒疫苗(5型腺病毒载体)

接种1剂。

3.重组新冠病毒疫苗(CHO细胞)

接种3剂;相邻2剂之间的接种间隔建议≥4周。第2剂尽量在接种第1剂次后8周内完成,第3剂尽量在接种第1剂次后6个月内完成。

(三)接种途径和接种部位

推荐上臂三角肌肌内注射。

三、其他有关事项

(一)迟种补种。

对2剂或3剂次程序的疫苗,未按程序完成接种者,建议尽早补种。免疫程序无需重新开始,补种完成相应剂次即可。

对在14天内完成2剂新冠病毒灭活疫苗接种者,在第2剂接种3周后尽早补种1剂灭活疫苗。对在14-21天完成2剂新冠病毒灭活疫苗接种的,无需补种。

(二)加强免疫。

现阶段暂不推荐加强免疫。

(三)与其他疫苗同时接种。

暂不推荐与其他疫苗同时接种。其他疫苗与新冠病毒疫苗的接种间隔应大于14天。当因动物致伤、外伤等原因需接种狂犬病疫苗、破伤风疫苗、免疫球蛋白时,可不考虑与新冠病毒疫苗的接种间隔。

(四)不同疫苗产品替换。

现阶段建议用同一个疫苗产品完成接种。如遇疫苗无法继续供应、受种者异地接种等特殊情况,无法用同一个疫苗产品完成接种时,可采用相同种类的其他生产企业的疫苗产品完成接种。

(五)新冠病毒感染及抗体筛查。

在疫苗接种前无需开展新冠病毒核酸及抗体检测;接种后也不建议常规检测抗体作为免疫成功与否的依据。

(六)接种禁忌。

通常的疫苗接种禁忌包括:(1)对疫苗的活性成分、任何一种非活性成分、生产工艺中使用的物质过敏者,或以前接种同类疫苗时出现过敏者;(2)既往发生过疫苗严重过敏反应者(如急性过敏反应、血管神经性水肿、呼吸困难等);(3)患有未控制的癫痫和其他严重神经系统疾病者(如横贯性脊髓炎、格林巴利综合症、脱髓鞘疾病等);(4)正在发热者,或患急性疾病,或慢性疾病的急性发作期,或未控制的严重慢性病患者;(5)妊娠期妇女。

本指南对说明书中所列部分接种禁忌或慎用人群,参照下述特定人群接种建议执行。

四、特定人群接种建议

(一)60岁及以上人群。

60岁及以上人群为感染新冠病毒后的重症、死亡高风险人群。目前,4个附条件批准上市的新冠病毒疫苗Ⅲ期临床试验研究纳入该人群的数量有限,暂无疫苗对该人群的保护效力数据。但Ⅰ/Ⅱ期临床研究数据显示,该人群疫苗接种安全性良好,与18-59岁人群相比,接种后中和抗体滴度略低,但中和抗体阳转率相似,提示疫苗对60岁以上人群也会产生一定的保护作用,建议接种。

(二)18岁以下人群。

目前已有的疫苗尚未获得用于该人群的临床试验数据,暂不推荐18岁以下人群接种。

(三)慢性病人群。

慢性病人群为感染新冠病毒后的重症、死亡高风险人群。健康状况稳定,药物控制良好的慢性病人群不作为新冠病毒疫苗接种禁忌人群,建议接种。

(四)育龄期和哺乳期女性。

如果在接种后怀孕或在未知怀孕的情况下接种了疫苗,基于对上述疫苗安全性的理解,不推荐仅因接种新冠病毒疫苗而采取特别医学措施(如终止妊娠),建议做好孕期检查和随访。对于有备孕计划的女性,不必仅因接种新冠病毒疫苗而延迟怀孕计划。

虽然目前尚无哺乳期女性接种新冠病毒疫苗对哺乳婴幼儿有影响的临床研究数据,但基于对疫苗安全性的理解,建议对新冠病毒感染高风险的哺乳期女性(如医务人员等)接种疫苗。考虑到母乳喂养对婴幼儿营养和健康的重要性,参考国际上通行做法,哺乳期女性接种新冠病毒疫苗后,建议继续母乳喂养。

(五)免疫功能受损人群。

免疫功能受损人群是感染新冠病毒后的重症、死亡高风险人群。目前尚无新冠病毒疫苗对该人群(例如恶性肿瘤、肾病综合征、艾滋病患者)、人类免疫缺陷病毒(HIV)感染者的安全性和有效性数据。该类人群疫苗接种后的免疫反应及保护效果可能会降低。对于灭活疫苗和重组亚单位疫苗,根据既往同类型疫苗的安全性特点,建议接种;对于腺病毒载体疫苗,虽然所用载体病毒为复制缺陷型,但既往无同类型疫苗使用的安全性数据,建议经充分告知,个人权衡获益大于风险后接种。

(六)既往新冠患者或感染者。

现有研究数据表明,新冠病毒感染后6个月内罕见再次感染发病的情况。既往新冠肺炎病毒感染者(患者或无症状感染者),在充分告知基础上,可在6个月后接种1剂。

五、其他事项

随着更多新冠病毒疫苗的获批使用、疫苗临床研究数据的不断完善以及疫苗上市后监测和评价数据的增加,根据疫情防控形势的需要,本指南将适时更新。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2083349, encodeId=650a2083349ac, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Fri Nov 19 20:31:30 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257967, encodeId=80d0125e96787, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Mar 31 05:31:30 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549676, encodeId=121e15496e60a, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed Mar 31 05:31:30 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029301, encodeId=df05102930195, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Mar 29 17:31:30 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952061, encodeId=a13f95206177, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b75b4745734, createdName=hanhan19890105, createdTime=Mon Mar 29 15:42:21 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952048, encodeId=705495204806, content=🎉, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00351992615, createdName=meimei6988, createdTime=Mon Mar 29 14:50:59 CST 2021, time=2021-03-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2083349, encodeId=650a2083349ac, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Fri Nov 19 20:31:30 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257967, encodeId=80d0125e96787, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Mar 31 05:31:30 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549676, encodeId=121e15496e60a, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed Mar 31 05:31:30 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029301, encodeId=df05102930195, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Mar 29 17:31:30 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952061, encodeId=a13f95206177, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b75b4745734, createdName=hanhan19890105, createdTime=Mon Mar 29 15:42:21 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952048, encodeId=705495204806, content=🎉, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00351992615, createdName=meimei6988, createdTime=Mon Mar 29 14:50:59 CST 2021, time=2021-03-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2083349, encodeId=650a2083349ac, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Fri Nov 19 20:31:30 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257967, encodeId=80d0125e96787, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Mar 31 05:31:30 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549676, encodeId=121e15496e60a, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed Mar 31 05:31:30 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029301, encodeId=df05102930195, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Mar 29 17:31:30 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952061, encodeId=a13f95206177, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b75b4745734, createdName=hanhan19890105, createdTime=Mon Mar 29 15:42:21 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952048, encodeId=705495204806, content=🎉, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00351992615, createdName=meimei6988, createdTime=Mon Mar 29 14:50:59 CST 2021, time=2021-03-29, status=1, ipAttribution=)]
    2021-03-31 xxxx1054
  4. [GetPortalCommentsPageByObjectIdResponse(id=2083349, encodeId=650a2083349ac, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Fri Nov 19 20:31:30 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257967, encodeId=80d0125e96787, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Mar 31 05:31:30 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549676, encodeId=121e15496e60a, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed Mar 31 05:31:30 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029301, encodeId=df05102930195, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Mar 29 17:31:30 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952061, encodeId=a13f95206177, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b75b4745734, createdName=hanhan19890105, createdTime=Mon Mar 29 15:42:21 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952048, encodeId=705495204806, content=🎉, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00351992615, createdName=meimei6988, createdTime=Mon Mar 29 14:50:59 CST 2021, time=2021-03-29, status=1, ipAttribution=)]
    2021-03-29 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2083349, encodeId=650a2083349ac, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Fri Nov 19 20:31:30 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257967, encodeId=80d0125e96787, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Mar 31 05:31:30 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549676, encodeId=121e15496e60a, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed Mar 31 05:31:30 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029301, encodeId=df05102930195, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Mar 29 17:31:30 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952061, encodeId=a13f95206177, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b75b4745734, createdName=hanhan19890105, createdTime=Mon Mar 29 15:42:21 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952048, encodeId=705495204806, content=🎉, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00351992615, createdName=meimei6988, createdTime=Mon Mar 29 14:50:59 CST 2021, time=2021-03-29, status=1, ipAttribution=)]
    2021-03-29 hanhan19890105

    有用

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2083349, encodeId=650a2083349ac, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Fri Nov 19 20:31:30 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257967, encodeId=80d0125e96787, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Mar 31 05:31:30 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549676, encodeId=121e15496e60a, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed Mar 31 05:31:30 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029301, encodeId=df05102930195, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Mar 29 17:31:30 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952061, encodeId=a13f95206177, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b75b4745734, createdName=hanhan19890105, createdTime=Mon Mar 29 15:42:21 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952048, encodeId=705495204806, content=🎉, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00351992615, createdName=meimei6988, createdTime=Mon Mar 29 14:50:59 CST 2021, time=2021-03-29, status=1, ipAttribution=)]
    2021-03-29 meimei6988

    🎉

    0

相关资讯

全国3亿人失眠! 打了新冠疫苗更应该重视,睡不好或影响疫苗效果

若是一周内出现三次以上失眠并且持续三个月以上,应及时到医院就诊,查找病因、明确诊断、综合治疗,以免贻误病情。

全国新冠病毒疫苗接种剂次已超1亿剂次!**日接种超过610万剂次,国内**有望达到每日1000万剂次

3月28日,国务院联防联控机制举办新闻发布会,国家卫生健康委新闻发言人、宣传司副司长米锋介绍,截至3月27日24时,全国累计报告接种新冠病毒疫苗超过一亿剂次。

中国开展“史上大规模”疫苗接种

日接种剂次甚至可能为人类公共卫生行动创下新标杆。

2021年3月27日全球新冠肺炎(COVID-19)疫情简报,确诊超1亿2667万,国内日接种超过500万剂次

Worldometers世界实时统计数据显示,截至北京时间2021年3月27日8时01分,全球累计确诊新冠肺炎(COVID-19)病例超过12667万例,新增612,326例,达到126,673,20

柳叶刀:有效率达95%的COVID-19疫苗能为英国带来1000亿英镑的净值

根据发表在《柳叶刀传染病》上的新研究显示,安全且能够达到95%有效率的COVID-19疫苗,若能对疾病和感染提供三年保护,可以为英国创造1000亿英镑的净值。

Baidu
map
Baidu
map
Baidu
map